Internal Medicine, Hematology & Oncology · Springfield, MO
NPI
1164477014
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
3850 S National Ave Ste 600
Springfield, MO, 65807
Phone (417) 882-4880
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
52,338 services
Medicare patients, 2024
531
Average age 74
Drug cost, 2024
$4.2M
1,677 prescriptions
Company payments, 2025
$471
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dushyant Verma was code J9271 (injection, pembrolizumab, 1 mg), 10,500 times for 11 patients. In total Dushyant Verma billed 52,338 services in 126 codes, and Medicare paid $1.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 10,500 | 11 | $44.67 | $469K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 3,780 | 11 | $39.30 | $149K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,680 | 12 | $15.42 | $26K |
| J0897 Injection, denosumab, 1 mg | Office | 1,440 | 12 | $20.60 | $30K |
| 99214 Office E&M - Established | Office | 815 | 341 | $85.05 | $69K |
| 85025 Blood Count | Office | 797 | 265 | $7.60 | $6,056 |
| 36415 Venipuncture Blood Collection | Office | 651 | 266 | $8.61 | $5,607 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 601 | 31 | $0.09 | $53.74 |
| 80053 Clinical Chemistry | Office | 443 | 181 | $10.32 | $4,572 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 300 | 16 | $0.73 | $218 |
| 85045 Blood Count | Office | 187 | 109 | $3.91 | $731 |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 140 | 20 | $69.44 | $9,722 |
| 96413 Chemotherapy Administration | Office | 136 | 52 | $82.98 | $11K |
| 96372 Injection Administration | Office | 126 | 58 | $9.53 | $1,201 |
| 99213 Office E&M - Established | Office | 123 | 104 | $58.51 | $7,196 |
By year: 2022 $1.4M for 88,416 services; 2023 $1.3M for 73,988 services; 2024 $1.4M for 52,338 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 797 | 265 | $7.60 | $6,056 |
| 36415 Venipuncture Blood Collection | 651 | 266 | $8.61 | $5,607 |
| 80053 Clinical Chemistry | 443 | 181 | $10.32 | $4,572 |
| 85045 Blood Count | 187 | 109 | $3.91 | $731 |
| 81002 Clinical Chemistry | 32 | 15 | $3.41 | $109 |
Medicare prescription drug claims, 2024
In 2024, the drug Dushyant Verma prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 124 prescriptions and refills. In total Dushyant Verma wrote 1,677 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 124 | 124 | 35 | $2,658 |
| Morphine Sulfate Er Morphine Sulfate | 93 | 93 | 23 | $2,152 |
| Letrozole Generic | 84 | 150 | 23 | $1,563 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 79 | 79 | 21 | $1,759 |
| Imbruvica Ibrutinib | 72 | 72 | Under 11 | $1.1M |
| Oxycodone Hcl Generic | 71 | 71 | 19 | $1,154 |
| Anastrozole Generic | 64 | 113 | 15 | $444 |
| Alprazolam Generic | 56 | 57 | 11 | $292 |
| Hydroxyurea Generic | 47 | 108 | 13 | $963 |
| Prochlorperazine Maleate Generic | 41 | 41 | 17 | $649 |
| Prednisone Generic | 39 | 51 | 16 | $205 |
| Eliquis Apixaban | 35 | 35 | Under 11 | $20K |
| Levothyroxine Sodium Generic | 31 | 37 | Under 11 | $123 |
| Ondansetron Hcl Generic | 31 | 32 | 11 | $706 |
| Gabapentin Generic | 30 | 36 | Under 11 | $504 |
Brand drugs: - claims; generic drugs: 1,253 claims; opioid claims: 406.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dushyant Verma $471 ($471 in general payments such as food, travel and fees) from 13 companies. The largest payer was Janssen Biotech, Inc. with $122.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 1 | $122 |
| Aveo Pharmaceuticals, Inc. | 1 | $91.4 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $32.92 |
| Abbvie Inc. ABBV | 1 | $30.27 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $26.32 |
| Exelixis Inc. EXEL | 1 | $26.18 |
| Daiichi Sankyo Inc. 4568.T | 1 | $26.18 |
| Pharmacosmos Therapeutics Inc. | 1 | $22.41 |
| Gilead Sciences, Inc. GILD | 1 | $21.46 |
| Merck Sharp & Dohme LLC MRK | 1 | $20.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.